Physician profile
Keith Dung
NPI 1083782791
$2,453.95
in general payments reported to CMS, 2019-2025
11 companies · $524 in 2025
The $524 reported for 2025 was more than what 91% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $18.03 · 2021: $75.34 · 2022: $12.96 · 2023: $844 · 2024: $499 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412 · Education: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.72 |
| Education | $454.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $840.47 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $425.36 | 2019 | |
| Nobel Biocare USA | $332.26 | 2019-2023 | Nobelactive |
| Envista Holdings Corporation | $185.75 | 2024-2025 | Herculite Ultra, Instrumentarium Op300 |
| Align Technology, INC. | $160.95 | 2024 | Invisalign |
| Patterson Companies, INC. | $154.17 | 2023 | |
| Dentsply Sirona INC | $124.52 | 2021-2024 | Vortex Blue Conform Fit |
| Voco America INC. | $108.92 | 2022-2025 | Meron Plus Qm, Futurabond U, Admira Fusion X-Tra |
| Kerr Corporation | $91.32 | 2023 | Zirconia Abutment Preparation Kit |
| Tulsa Dental Products LLC | $15.15 | 2019 | |
| Solventum Corporation | $15.08 | 2024 | 3m |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Dung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.